Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.

During a clinical trial of duration of chemotherapy in small cell lung cancer (SCLC), 71 of 610 patients (11.6%) died in the first 3 weeks. Chemotherapy consisted of cyclophosphamide 1 g m-2 i.v. day 1, etoposide 100 mg t.d.s. orally days 1-3, vincristine 2 mg i.v. day 1. The time of death was found...

Descripción completa

Detalles Bibliográficos
Autores principales: Morittu, L., Earl, H. M., Souhami, R. L., Ash, C. M., Tobias, J. S., Geddes, D. M., Harper, P. G., Spiro, S. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247207/
https://www.ncbi.nlm.nih.gov/pubmed/2544222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247207/
https://www.ncbi.nlm.nih.gov/pubmed/2544222

Ejemplares similares